ENO1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.003200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.131400E-01
Normal-vs-Stage2
7.709600E-01
Normal-vs-Stage3
6.463200E-01
Normal-vs-Stage4
8.405200E-01
Stage1-vs-Stage2
1.671370E-01
Stage1-vs-Stage3
7.872800E-01
Stage1-vs-Stage4
2.984000E-01
Stage2-vs-Stage3
3.876400E-01
Stage2-vs-Stage4
8.973800E-01
Stage3-vs-Stage4
5.209200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.183600E-01
Normal-vs-AfricanAmerican
4.285000E-01
Normal-vs-Asian
6.842800E-01
Caucasian-vs-AfricanAmerican
1.074010E-01
Caucasian-vs-Asian
4.328200E-01
AfricanAmerican-vs-Asian
1.847030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.799800E-01
Normal-vs-Female
8.125600E-01
Male-vs-Female
3.512000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.918200E-01
Normal-vs-Age(41-60Yrs)
6.090800E-01
Normal-vs-Age(61-80Yrs)
8.909400E-01
Normal-vs-Age(81-100Yrs)
7.705200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.949800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.143400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.104600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.970030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.006000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.328200E-01
Normal-vs-Daily Drinker
7.864600E-01
Normal-vs-Weekly Drinker
8.654000E-01
Normal-vs-Occasional Drinker
4.963200E-01
Normal-vs-Social Drinker
9.333000E-01
Non Drinker-vs-Daily Drinker
3.340400E-01
Non Drinker-vs-Weekly Drinker
4.897400E-01
Non Drinker-vs-Occasional Drinker
7.243900E-02
Non Drinker-vs-Social Drinker
5.797800E-01
Daily Drinker-vs-Weekly Drinker
9.221600E-01
Daily Drinker-vs-Occasional Drinker
2.777600E-01
Daily Drinker-vs-Social Drinker
7.156400E-01
Weekly Drinker-vs-Occasional Drinker
3.436000E-01
Weekly Drinker-vs-Social Drinker
8.390800E-01
Occasional Drinker-vs-Social Drinker
2.108600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.537000E-01
Normal-vs-Grade 2
7.699800E-01
Normal-vs-Grade 3
8.181400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.537340E-03
Grade 1-vs-Grade 3
9.382200E-04
Grade 1-vs-Grade 4
6.537000E-01
Grade 2-vs-Grade 3
3.246000E-01
Grade 2-vs-Grade 4
7.699800E-01
Grade 3-vs-Grade 4
8.181400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.821800E-01
Normal-vs-NonDiabetic
8.518600E-01
Diabetic-vs-NonDiabetic
5.879200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.066200E-01
Normal-vs-NoPancreatitis
8.911600E-01
Pancreatitis-vs-NoPancreatitis
9.304200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.100000E-01
Normal-vs-N1
7.964400E-01
N0-vs-N1
6.462300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.130000E-01
Normal-vs-TP53-NonMutant
1.796160E-01
TP53-Mutant-vs-TP53-NonMutant
3.13679970886938E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
